Bionano genomics announces issuance of two u.s. patents for novel methods that expand patent protection for uses of nanochannel arrays in genome analysis

San diego, april 14, 2022 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo), pioneer of optical genome mapping (ogm) solutions on the saphyr® system and provider of nxclinical™ software, the leading solution for visualization, interpretation and reporting of genomic data, today announced that the united states patent and trademark office issued two new us patents, no. 11,291,999 and no. 11,292,713 on april 5, 2022.
BNGO Ratings Summary
BNGO Quant Ranking